BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,160,000 | +8.7% | 7,673 | +4.8% | 0.01% | +16.7% |
| Q2 2022 | $1,067,000 | +13.9% | 7,321 | -7.4% | 0.01% | +20.0% |
| Q1 2022 | $937,000 | -24.3% | 7,905 | -11.9% | 0.01% | -16.7% |
| Q4 2021 | $1,237,000 | +64.5% | 8,975 | +65.8% | 0.01% | +50.0% |
| Q3 2021 | $752,000 | +43.2% | 5,413 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $525,000 | +32.9% | 5,413 | -6.3% | 0.00% | +50.0% |
| Q1 2021 | $395,000 | -32.0% | 5,774 | -14.9% | 0.00% | -50.0% |
| Q4 2020 | $581,000 | +65.5% | 6,782 | +25.7% | 0.00% | +100.0% |
| Q3 2020 | $351,000 | -11.1% | 5,397 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $395,000 | +240.5% | 5,397 | +58.5% | 0.00% | +200.0% |
| Q1 2020 | $116,000 | -37.3% | 3,405 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $185,000 | +69.7% | 3,405 | +30.1% | 0.00% | 0.0% |
| Q3 2019 | $109,000 | +10.1% | 2,618 | +16.0% | 0.00% | 0.0% |
| Q2 2019 | $99,000 | +65.0% | 2,256 | +94.7% | 0.00% | 0.0% |
| Q1 2019 | $60,000 | +1.7% | 1,159 | -27.9% | 0.00% | 0.0% |
| Q4 2018 | $59,000 | -1.7% | 1,608 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $60,000 | +53.8% | 1,608 | +62.3% | 0.00% | – |
| Q2 2018 | $39,000 | +2.6% | 991 | -32.1% | 0.00% | – |
| Q1 2018 | $38,000 | -2.6% | 1,459 | 0.0% | 0.00% | – |
| Q4 2017 | $39,000 | – | 1,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |